Boston Scientific Corp. (0HOY)
LSE
Closed
Oct 7, 2026
Day's Range
41.8352 wk Range
41.58Overview - 0HOY - Boston Scientific Corp.
Key Statistics
Valuation
Enterprise Value
77.12B
P/E (Trailing)
‪0.83‬
Price / Sales (TTM)
‪16.14‬
Price / Book
‪2.57‬
EV / EBITDA
‪13.50‬
Profitability
Gross Margin
‪4.84%‬
Profit Margin
‪17.49%‬
Operating Margin
‪22.89%‬
Return on Assets
‪6.19%‬
Return on Equity
‪15.33%‬
Ownership
Shares Outstanding
1.38B
Float
1.44B
Held by Insiders
‪0.25%‬
Held by Institutions
‪94.73%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪63.51‬
200-Day Avg
‪55.52‬
Dividends
Frequency
Annual
Market Cap - 0HOY - Boston Scientific Corp.
Peers - 0HOY - Boston Scientific Corp.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0HOYLSEBoston Scientific Corp.60.27BMarket Cap-123.45%52-week change0.84P/E (Trailing)‪17.49%‬Profit Margin
- SVSLSESavills PLC177.85BMarket Cap+15.05%52-week change22.83P/E (Trailing)‪2.49%‬Profit Margin
- 0Q15LSEAbbott Laboratories168.67BMarket Cap-38.26%52-week change45.46P/E (Trailing)‪12.91%‬Profit Margin
- 0Y6XLSEMedtronic plc118.72BMarket Cap-6.44%52-week change0.24P/E (Trailing)‪13.93%‬Profit Margin
- 0R2SLSEStryker Corp.102.51BMarket Cap-34.20%52-week change0.52P/E (Trailing)‪14.43%‬Profit Margin
- PRNLSEPrinces Group plc81.73BMarket Cap-42.22%52-week change23.86P/E (Trailing)‪1.90%‬Profit Margin
- 0RGTLSEDemant A/S76.63BMarket Cap+25.99%52-week change29.38P/E (Trailing)‪7.55%‬Profit Margin
Profile Summary - 0HOY - Boston Scientific Corp.
About
Boston Scientific Corp. is a medical device company focused on developing, manufacturing, and marketing technologies used in interventional medical procedures worldwide. The company’s portfolio serves a broad range of clinical areas, including cardiology, peripheral interventions, endoscopy, urology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
